BioTechne Corp (TECH)
(Delayed Data from NSDQ)
$62.66 USD
-0.86 (-1.35%)
Updated Apr 25, 2024 04:00 PM ET
After-Market: $62.66 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Income Statements
Fiscal Year end for BioTechne Corp falls in the month of June .
All items in Millions except EPS data.
6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 | |
---|---|---|---|---|---|
Sales | 1,137 | 1,106 | 931 | 739 | 714 |
Cost Of Goods | 367 | 349 | 298 | 256 | 241 |
Gross Profit | 770 | 757 | 633 | 483 | 473 |
Selling & Adminstrative & Depr. & Amort Expenses | 471 | 460 | 396 | 326 | 327 |
Income After Depreciation & Amortization | 299 | 297 | 237 | 157 | 147 |
Non-Operating Income | 51 | 16 | -75 | 138 | -13 |
Interest Expense | 11 | 11 | 14 | 19 | 22 |
Pretax Income | 339 | 301 | 148 | 276 | 112 |
Income Taxes | 53 | 38 | 9 | 47 | 16 |
Minority Interest | 0 | -9 | -1 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 285 | 263 | 140 | 229 | 96 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 285 | 272 | 140 | 229 | 96 |
Depreciation Footnote | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 406 | 398 | 325 | 240 | 225 |
Depreciation & Amortization (Cash Flow) | 107 | 101 | 88 | 83 | 78 |
Income After Depreciation & Amortization | 299 | 297 | 237 | 157 | 147 |
Earnings Per Share Data | 6/30/23 | 6/30/22 | 6/30/21 | 6/30/20 | 6/30/19 |
---|---|---|---|---|---|
Average Shares | 161.86 | 164.12 | 161.93 | 157.60 | 155.57 |
Diluted EPS Before Non-Recurring Items | 1.79 | 1.75 | 1.43 | 0.97 | 0.95 |
Diluted Net EPS (GAAP) | 1.76 | 1.66 | 0.87 | 1.46 | 0.62 |
Fiscal Year end for BioTechne Corp falls in the month of June .
All items in Millions except EPS data.
3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 | |
---|---|---|---|---|---|
Sales | NA | 272.60 | 276.94 | 301.32 | 294.15 |
Cost Of Goods | NA | 96.01 | 91.74 | 96.62 | 91.98 |
Gross Profit | NA | 176.59 | 185.19 | 204.70 | 202.16 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 138.59 | 129.33 | 110.17 | 121.95 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 38.00 | 55.86 | 94.53 | 80.21 |
Non-Operating Income | NA | -4.62 | -6.30 | 1.60 | -0.02 |
Interest Expense | NA | 0.00 | 0.00 | 11.22 | 0.00 |
Pretax Income | NA | 33.39 | 49.56 | 88.32 | 80.20 |
Income Taxes | NA | 5.92 | -1.44 | 12.83 | 9.98 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | 27.47 | 50.99 | 75.48 | 70.22 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | 27.47 | 50.99 | 75.48 | 70.22 |
Earnings Per Share Data | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | 3/31/23 |
---|---|---|---|---|---|
Average Shares | NA | 160.06 | 161.94 | 161.92 | 161.62 |
Diluted EPS Before Non-Recurring Items | NA | 0.33 | 0.35 | 0.56 | 0.47 |
Diluted Net EPS (GAAP) | NA | 0.17 | 0.31 | 0.47 | 0.43 |